Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer.

Apyrase Carcinoma, Ovarian Epithelial / genetics Female Hepatitis A Virus Cellular Receptor 2 Humans Ovarian Neoplasms / pathology Programmed Cell Death 1 Receptor / genetics Receptors, Immunologic
CD39 PD-1 TIGIT TIL ascites co-expression differentiation ovarian cancer γδ T cells

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 03 2022
Historique:
received: 16 02 2022
revised: 06 03 2022
accepted: 09 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 14 4 2022
Statut: epublish

Résumé

Phenotypic characterization of γδ T cells in the MALs (malignant ascites lymphocytes), TILs (tumor infiltrating lymphocytes), and PBLs (peripheral blood lymphocytes) of ovarian cancer (OvCA) patients is lacking. Therefore, we quantified γδ T cell prevalence in MAL, TIL, and PBL specimens from

Identifiants

DOI: 10.3390/cells11060964 PMID: 35326415 PMC: PMC8946192
pubmed: 35326415
pii: cells11060964
doi: 10.3390/cells11060964
pmc: PMC8946192
pii:
doi:

Substances chimiques

HAVCR2 protein, human 0
Hepatitis A Virus Cellular Receptor 2 0
PDCD1 protein, human 0
Programmed Cell Death 1 Receptor 0
Receptors, Immunologic 0
TIGIT protein, human 0
Apyrase EC 3.6.1.5
ENTPD1 protein, human EC 3.6.1.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Federal Ministry of Education and Research
ID : 13GW0407

Références

Clin Cancer Res. 2018 Sep 1;24(17):4175-4186
pubmed: 29437767
J Immunol. 2012 May 1;188(9):4701-8
pubmed: 22467661
J Immunol. 2019 Jul 15;203(2):311-320
pubmed: 31285310
Trends Immunol. 2015 Apr;36(4):265-76
pubmed: 25797516
Eur J Immunol. 2011 Feb;41(2):345-55
pubmed: 21268005
Front Immunol. 2014 Nov 11;5:575
pubmed: 25426121
Immunity. 2016 May 17;44(5):989-1004
pubmed: 27192565
Oncoimmunology. 2018 Dec 14;8(3):1550618
pubmed: 30723581
Immunol Rev. 2020 Nov;298(1):84-98
pubmed: 33048357
Blood Adv. 2021 Apr 13;5(7):1816-1829
pubmed: 33787861
Curr Opin Pharmacol. 2020 Aug;53:66-76
pubmed: 32777746
Cell Mol Gastroenterol Hepatol. 2021;12(2):443-464
pubmed: 33781741
Front Immunol. 2018 Nov 27;9:2636
pubmed: 30538697
Exp Mol Med. 2021 Mar;53(3):318-327
pubmed: 33707742
Biomedicines. 2021 Sep 21;9(9):
pubmed: 34572463
Cancer Immunol Res. 2017 May;5(5):397-407
pubmed: 28351891
Cell Death Dis. 2018 May 23;9(6):616
pubmed: 29795285
J Clin Invest. 2015 May;125(5):2046-58
pubmed: 25866972
Nat Commun. 2018 Jul 13;9(1):2724
pubmed: 30006565
Oncoimmunology. 2017 Sep 14;7(1):e1364828
pubmed: 29296515
Clin Cancer Res. 2014 Nov 15;20(22):5720-32
pubmed: 24893631
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33472952
Oncoimmunology. 2017 Jul 13;6(10):e1347742
pubmed: 29123962
Front Immunol. 2018 Apr 27;9:929
pubmed: 29755480
Cancer. 2007 Jan 15;109(2):221-7
pubmed: 17154394
Cancer Immunol Immunother. 2020 Dec;69(12):2571-2587
pubmed: 32588076
Clin Cancer Res. 2018 Sep 1;24(17):4187-4200
pubmed: 29444930
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629
pubmed: 32514148
Cell Mol Immunol. 2020 Sep;17(9):925-939
pubmed: 32699351
Oncoimmunology. 2021 Jun 21;10(1):1930391
pubmed: 34211801
Front Oncol. 2019 Oct 25;9:1066
pubmed: 31709176
Immunity. 2014 May 15;40(5):785-800
pubmed: 24816404
J Transl Med. 2019 May 7;17(1):144
pubmed: 31064389
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Biochem Biophys Res Commun. 2016 Sep 23;478(3):1298-303
pubmed: 27553282
Oncoimmunology. 2013 Jan 1;2(1):e22892
pubmed: 23483102
Oncoimmunology. 2017 Jan 6;6(2):e1277305
pubmed: 28344891
Nat Rev Immunol. 2020 Mar;20(3):173-185
pubmed: 31676858
Cancer Res. 2015 Nov 1;75(21):4494-503
pubmed: 26363007
Exp Cell Res. 2020 Jan 1;386(1):111719
pubmed: 31726050
Oncoimmunology. 2013 Mar 1;2(3):e23304
pubmed: 23802074
Cancers (Basel). 2020 Dec 11;12(12):
pubmed: 33322519
Front Immunol. 2018 Dec 05;9:2783
pubmed: 30568654
Cell Mol Immunol. 2020 Sep;17(9):914-924
pubmed: 32709926
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
Eur J Immunol. 2022 Jan;52(1):96-108
pubmed: 34505280
PLoS One. 2012;7(11):e49878
pubmed: 23189169
Front Med (Lausanne). 2021 Nov 08;8:763773
pubmed: 34820398
J Immunother Cancer. 2019 Nov 29;7(1):331
pubmed: 31783783
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14
pubmed: 27743768
J Transl Med. 2018 Jan 10;16(1):3
pubmed: 29316940
J Immunother Cancer. 2020 Sep;8(2):
pubmed: 32900861

Auteurs

Pauline Weimer (P)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Jasmin Wellbrock (J)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Tabea Sturmheit (T)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
2cureX GmbH, 20251 Hamburg, Germany.

Leticia Oliveira-Ferrer (L)

Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Yi Ding (Y)

Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Stephan Menzel (S)

Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Institute of Immunology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Marius Witt (M)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Louisa Hell (L)

2cureX GmbH, 20251 Hamburg, Germany.

Barbara Schmalfeldt (B)

Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Carsten Bokemeyer (C)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Walter Fiedler (W)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
ORCID: 0000-0003-0275-8803

Franziska Brauneck (F)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Acid anhydride hydrolases › Apyrase › Tissue-Specific Expression of TIGIT, PD-1,...
questionsmedicales.fr › Maladies endocriniennes › Troubles gonadiques › Maladies ovariennes › Tumeurs de l'ovaire › Carcinome épithélial de l'ovaire › Tissue-Specific Expression of TIGIT, PD-1,...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs viraux › Récepteur cellulaire-2 du virus de l'hépatite A › Tissue-Specific Expression of TIGIT, PD-1,...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tissue-Specific Expression of TIGIT, PD-1,...
questionsmedicales.fr › Maladies endocriniennes › Troubles gonadiques › Maladies ovariennes › Tumeurs de l'ovaire › Tissue-Specific Expression of TIGIT, PD-1,...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes T › Récepteur-1 de mort cellulaire programmée › Tissue-Specific Expression of TIGIT, PD-1,...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Tissue-Specific Expression of TIGIT, PD-1,...